NASDAQ : AVR
Anteris Technologies Global Corp. — Key statistics
Healthcare · Medical Instruments & Supplies · Australia
Last price 6.31 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 615.18M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 566.92M |
| Enterprise Value | 313.38M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 97.49M |
| Shares Outstanding | 97.49M |
| Shares Change (YoY) | +120.35% |
| Shares Change (QoQ) | +17.26% |
| Owned by Insiders (%) | 0.91% |
| Owned by Institutions (%) | 57.77% |
| Float | 68.50M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 249.82 |
| Forward PS | 50.88 |
| PB Ratio | 2.45 |
| P/TBV Ratio | 2.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 136.73 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 14.20 |
| Quick Ratio | 14.02 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -580.51 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -74.65% |
| Return on Assets (ROA) | -42.51% |
| Return on Invested Capital (ROIC) | -47.12% |
| Return on Capital Employed (ROCE) | -41.80% |
| Weighted Average Cost of Capital (WACC) | 8.22% |
| Revenue Per Employee | $12,885 |
| Profits Per Employee | -$595,195 |
| Employee Count | 174 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 2.46 |
Taxes
| Measure | Value |
|---|
| Income Tax | 492,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.73 |
| 52-Week Price Change | +28.73% |
| 50-Day Moving Average | 7.49 |
| 200-Day Moving Average | 7.39 |
| Relative Strength Index (RSI) | 33.30 |
| Average Volume (20 Days) | 1,674,928 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 7.93M |
| Short Previous Month | 6.67M |
| Short % of Shares Out | 8.14% |
| Short % of Float | 11.58% |
| Short Ratio (days to cover) | 6.50 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 2.24M |
| Gross Profit | 1.68M |
| Operating Income | -106.23M |
| Pretax Income | -102.42M |
| Net Income | -103.56M |
| EBITDA | -104.50M |
| EBIT | -106.23M |
| Loss Per Share | -$1.62 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 256.87M |
| Total Debt | 3.32M |
| Net Cash | 253.55M |
| Net Cash Per Share | $2.60 |
| Equity (Book Value) | 251.67M |
| Book Value Per Share | 2.58 |
| Working Capital | 242.29M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -86.26M |
| Capital Expenditures | -1.95M |
| Depreciation & Amortization | 1.74M |
| Net Borrowing | -1.26M |
| Free Cash Flow | -88.21M |
| FCF Per Share | -$0.90 |
Margins
| Measure | Value |
|---|
| Gross Margin | 74.98% |
| Operating Margin | -4,738.36% |
| Pretax Margin | -4,568.02% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -120.35% |
| Shareholder Yield | -120.35% |
| Earnings Yield | -27.83% |
| FCF Yield | -15.75% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $14.00 |
| Price Target Difference | 140.76% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 104.29% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 8.77 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |